Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3905538 | 0.67 | — | — | |
| SCHEMBL9052467 | 0.67 | TSHR (0.39) | TSHR | |
| SCHEMBL717592 | 0.67 | TSHR (0.36) | TSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL10683777 | 0.65 | — | — | |
| SCHEMBL3905585 | 0.63 | — | — | |
| SCHEMBL7522331 | 0.63 | TSHR (0.33) | TSHRHSD17B10 | |
| SCHEMBL8766 | 0.62 | — | — | |
| SCHEMBL13572157 | 0.60 | — | — | |
| SCHEMBL9492808 | 0.60 | — | — | |
| SCHEMBL13572269 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3908286-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2021-11-17 | — | — | EP | disclosed |
| WO-2020146397-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2020-07-16 | — | — | WO | disclosed |
| CN-110506121-A | The cutting reagent of sulfur-bearing hydroxyl and oxidation rinsing agent | INTELLIGENT BIO SYSTEMS INC | 2019-11-26 | — | — | CN | disclosed |
| EP-3535407-A1 | THIOL-CONTAINING CLEAVE REAGENTS AND OXIDATIVE WASH | Qiagen Sciences, LLC (US) | 2019-09-11 | — | — | EP | disclosed |
| CN-110168346-A | Multiplex imaging using MERISH, extended microscopy and related techniques | 哈佛学院院长及董事 | 2019-08-23 | — | — | CN | disclosed |
| CN-110140175-A | Matrix imprinting and clearance | 哈佛学院院长及董事 | 2019-08-16 | — | — | CN | disclosed |
| CN-109476694-A | Nucleotide analog | 奇根科学有限责任公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-107001460-A | Selective reduction of cysteine residues in Il-17 antibodies | 诺华股份有限公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106715768-A | System and method for assaying nucleic acids | 哈佛学院院长及董事 | 2017-05-24 | — | — | CN | disclosed |
| US-9371521-B2 | Substituted pyrazinedithiol reducing agents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-06-21 | — | — | US | disclosed |
| US-7163932-B2 | Aryldifluoromethylphosphonic acids for treatment of diabetes | MERCK FROSST CANADA & CO. (CA) | 2007-01-16 | — | — | US | disclosed |
| EP-1558283-A2 | HCV VACCINE COMPOSITIONS COMPRISING E1 AND NS3 PEPTIDES | INNOGENETICS N.V. (BE) | 2005-08-03 | — | — | EP | disclosed |
| WO-2004041853-A2 | HCV VACCINE COMPOSITIONS COMPRISING E1 AND NS3 PEPTIDES | INNOGENETICS N.V. (BE) | 2004-05-21 | — | — | WO | disclosed |
| EP-0888543-A4 | AZATIDE PEPTIDOMIMETICS | SCRIPPS RESEARCH INST (US) | 2004-04-07 | — | — | EP | disclosed |
| US-6465444-B2 | PROTEIN TYROSINE PHOSPHATASES(PTP-1B); ANTIDIABETIC, ANTITUMOR AND ANOREXIGENIC AGENTS; COMBINATION THERAPY | MERCK FROSST CANADA & CO. | 2002-10-15 | — | — | US | disclosed |
| EP-0888543-A1 | AZATIDE PEPTIDOMIMETICS | The Scripps Research Institute (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997035199-A9 | AZATIDE PEPTIDOMIMETICS | — | 1997-12-11 | — | — | WO | disclosed |
| WO-1997035199-A1 | AZATIDE PEPTIDOMIMETICS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1996040107-A1 | THE USE OF N,N'-BIS(MERCAPTOACETYL) HYDRAZINE DRIVATIVES AS ANTICATARACT AGENTS | ALCON LABORATORIES, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1993021303-A2 | ENHANCED PURIFICATION AND EXPRESSION OF INSOLUBLE RECOMBINANT PROTEINS | CHIRON CORPORATION (US) | 1993-10-28 | — | — | WO | disclosed |